Health Care Financing Analyst
Chairman Pitts, Ranking Member Pallone, and distinguished Subcommittee Members, I am Cliff Binder, Health Financing Analyst with the Congressional Research Service. I appreciate the opportunity to be here today to provide an overview on Medicare Part B prescription drugs – what they are and how Medicare reimburses providers for these products. I also will provide context by discussing recently introduced legislation and the potential effect of sequestration on Medicare Part B drug payments. Part B drug reimbursement is complex, I am presenting the major points that I hope will be most useful in facilitating today’s discussion.
Date of Report: June 28, 2013
Number of Pages: 9
Order Number: T-062813
For email and phone orders, provide a Visa, MasterCard, American Express, or Discover card number, expiration date, and name on the card. Indicate whether you want e-mail or postal delivery. Phone orders are preferred and receive priority processing